EN DE
STOCK COMPARISON

Colgate-Palmolive (India) vs Procter & Gamble: Fair Value & Quality

Both stocks run through our valuation models. Here is how Colgate-Palmolive (India) (500830) and Procter & Gamble (PG) compare, as of Aug 14, 2026.

As of Aug 14, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: Colgate-Palmolive (India) trades at ₹1,981 versus a fair value of ₹835 (-58%), while Procter & Gamble trades at $144 versus $108 (-25%).
Colgate-Palmolive (India)
500830.BSE · INR
-58%
upside to fair value
overvalued
Price₹1,981
Fair Value₹835
Quality82/100
Procter & Gamble
PG · USD · Consumer Staples
-25%
upside to fair value
overvalued
Price$144
Fair Value$108
Quality75/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Colgate-Palmolive (India)Procter & Gamble
Valuation
45.0×P/E (TTM)21.5×
P/S (TTM)3.95×
0.31×P/B6.58×
EV/EBITDA14.3×
PEG4.13×
Dividend yield2.9%
Dividend per share$4.23
Profitability
0%Net margin19%
0%Operating margin23%
Return on equity31%
0%Return on assets11%
Growth
0%Revenue growth (YoY)7%
4.6%Avg. growth/yr (3Y)1.7%
4.3%Avg. growth/yr (5Y)3.5%
Balance & size
Debt / equity0.48×
$5BMarket cap$342B
mixedGrowth qualityhealthy

Procter & Gamble leads: 3 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Colgate-Palmolive (India)of which business quality 83 · market factors 46 Procter & Gambleof which business quality 71 · market factors 51
ProfitabilityMargins and returns on capital today
98
73
Quality GrowthAre margins and returns improving?
33
46
CashflowEarnings quality: real cash, not paper profit
89
65
Fin. StrengthBalance sheet, leverage, solvency risk
93
70
InvestmentDisciplined investing over empire-building
90
85
Low VolatilityCalm price path (market factor)
81
95
MomentumPrice trend over the last 3–12 months (market factor)
36
36
52W MomentumDistance to the 52-week high (market factor)
24
28
Net IssuanceBuybacks instead of dilution
82
91

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Colgate-Palmolive (India)

DCF Models₹1,178
Earnings-Based₹749
Multiples₹904
Asset-Based₹45.55
Growth DCF₹1,105
Economic Profit₹739
Growth Earnings₹942

23 of 23 models see the stock below the current price.

Procter & Gamble

DCF Models$97.73
Earnings-Based$85.21
Dividend Discount$59.55
Multiples$120
Asset-Based$14.97
Growth DCF$74.21
Economic Profit$68.20
Growth Earnings$112

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Colgate-Palmolive (India)
Bear ₹610Fair Value ₹835Bull ₹1,111
₹1,981 = current price (white tick)
Procter & Gamble
Bear $70.77Fair Value $108Bull $151
$144 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Colgate-Palmolive (India)

No peer data.

Procter & Gamble · Consumer Staples

Quality score75 · Top 25%
Fair value upside-25% · below median

Bottom line

As of Aug 14, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: Colgate-Palmolive (India) trades at ₹1,981 versus a fair value of ₹835 (-58%), while Procter & Gamble trades at $144 versus $108 (-25%).

Colgate-Palmolive (India) has the higher quality score (82/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.